Jagsonpal Pharma to hold 47th AGM on Sep 21, 2026, via video conference
Jagsonpal Pharmaceuticals will hold its 47th AGM on September 21, 2026, via video conference. The Register of Members will close from September 14 to September 21, 2026. The cut-off date for voting eligibility is September 14, 2026. Remote e-voting will be open from September 18 to September 20, 2026.
This is a standard procedural announcement regarding the Annual General Meeting and e-voting process. It does not contain new financial information or strategic decisions that would have a significant immediate impact on the company's stock or operations.
The announcement pertains to the scheduling of the Annual General Meeting and related procedural information, which is a routine corporate event. It does not contain any specific financial performance data or significant business developments that would strongly influence sentiment.
Jagsonpal Pharmaceuticals Limited has announced the details for its 47th Annual General Meeting (AGM), which will be held on Saturday, September 21, 2026, at 3:00 PM IST. The meeting will be conducted through video conference (VC) or other audio-visual means (OAVM), in accordance with the applicable provisions of the Companies Act, 2013, and SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
The company has sent the notice of the AGM along with the integrated annual report for the financial year 2025-26 to its members. The annual report and notice will also be available on the company's website (www.paisalo.in) and stock exchanges' websites (www.bseindia.com and www.nseindia.com), as well as on NSDL's e-voting platform (www.evoting.nsdl.com).
As per Section 91 of the Companies Act, the company's Register of Members and Share Transfer Books will remain closed from Saturday, September 14, 2026, to Saturday, September 21, 2026, both days inclusive. The cut-off date for determining the eligibility of members for voting and dividend purposes at the AGM has been set as Saturday, September 14, 2026.
Members will have the option to cast their votes remotely through e-voting prior to the AGM. The remote e-voting period will commence on Thursday, September 18, 2026, at 9:00 AM IST and will conclude on Friday, September 20, 2026, at 5:00 PM IST. Members who have cast their vote by remote e-voting before the AGM will still be entitled to attend the AGM but will not be able to vote again during the meeting.
Members holding shares as of the cut-off date of September 14, 2026, will have the opportunity to participate in the AGM and cast their votes electronically on the proposed resolutions. The notice provides detailed instructions for remote e-voting. Members who do not hold shares as of the cut-off date will consider this notice for informational purposes only.
Furthermore, the company has appointed Mr. Satish Kumar Jaiswal (ICSI Membership No. F9512) as a scrutinizer for the process of ensuring a fair and transparent voting procedure. For any queries regarding e-voting, members can refer to the FAQ section on www.evoting.nsdl.com, email evoting@nsdl.com, or call 022-4886 7000 / 022-2499 7000.
What to do with a filing like this
Jagsonpal Pharmaceuticals Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Jagsonpal Pharmaceuticals Limited. Read the original for the full detail.